Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;120(5):1216-24.
doi: 10.1097/ALN.0000000000000172.

Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States

Brian T Bateman  1 , Sonia Hernandez-Diaz, James P Rathmell, John D Seeger, Michael Doherty, Michael A Fischer, Krista F Huybrechts
Affiliations

Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States

Brian T Bateman et al. Anesthesiology. 2014 May.

Abstract

Background: There are few data regarding the utilization of opioids during pregnancy. The objective of this study was to define the prevalence and patterns of opioid use in a large cohort of pregnant women who were commercial insurance beneficiaries.

Methods: Data for the study were derived from a deidentified research database of women from across the United States who had both medical and prescription benefits. By using diagnostic codes, the authors defined a cohort of 534,500 women with completed pregnancies who were enrolled in a commercial insurance plan from 6 months before pregnancy through delivery.

Results: Overall, 76,742 women (14.4%) were dispensed an opioid at some point during pregnancy. There were 30,566 women (5.7%) dispensed an opioid during the first trimester, 30,434 women (5.7%) during the second trimester, and 34,906 women (6.5%) during the third trimester. Of these, 11,747 women (2.2%) were dispensed opioids three or more times during pregnancy. The most commonly dispensed opioids during pregnancy were hydrocodone (6.8%), codeine (6.1%), and oxycodone (2.0%). The prevalence of exposure at anytime during pregnancy decreased slightly during the study period from 14.9% for pregnancies that delivered in 2005 to 12.9% in 2011. The prevalence of exposure varied significantly by region and was lowest in the Northeast and highest in the South.

Conclusions: This study demonstrates that opioids are very common exposures during pregnancy. Given the small and inconsistent body of literature on their safety in pregnancy, these findings suggest a need for research in this area.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: SHD has consulted for Novartis, GlaxoSmithKlein-Biologics (Middlesex, England, United Kingdom) and AstraZenaca (London, England, United Kingdom) and JS is a consultant to Optum Insight (Eden Prairie, Minnesota, United States of America) and World Health Information Science Consultants, LLC (Newton, Massachusetts, United States of America), both for unrelated projects. The other authors declare no potential conflict of interest.

Figures

Figure 1
Figure 1. Among Patients Chronically Taking Opioids Prior to Pregnancy*, Patterns of Opioid Dispensing during (A) the First Trimester and (B) the Second Trimester. n=5,838
*Defined as patients who received 3 or more dispensings of an opioid pre-pregnancy (from −180 days to day prior to last menstrual period) during 3 separate months; analysis restricted to types of opioids with >100 pre-pregnancy chronic users
Figure 2
Figure 2
Temporal Trends in Opioid Dispensing During Pregnancy (overall) and by Trimester.
Figure 3
Figure 3
Temporal Trends in Opioid Dispensing During Pregnancy For the Four Most Commonly Prescribed Types.
Figure 4
Figure 4
Prevalence of Opioid Dispensing During Pregnancy (overall) by State.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138:507–13. - PubMed
    1. Thielke SM, Simoni-Wastila L, Edlund MJ, DeVries A, Martin BC, Braden JB, Fan MY, Sullivan MD. Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med. 2010;11:248–56. - PMC - PubMed
    1. Zerzan JT, Morden NE, Soumerai S, Ross-Degnan D, Roughead E, Zhang F, Simoni-Wastila L, Sullivan SD. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44:1005–10. - PubMed
    1. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166–75. - PMC - PubMed
    1. Brixner DI, Oderda GM, Roland CL, Rublee DA. Opioid expenditures and utilization in the Medicaid system. J Pain Palliat Care Pharmacother. 2006;20:5–13. - PubMed

Publication types

Substances